Characteristics of attenuated endothelium-dependent relaxation seen in rabbit intrapulmonary vein following chronic nitroglycerine administration

British Journal of Pharmacology

Volumn 145, Issue 2, 2005, Pages 193-202

  Kusama, Nobuyoshi ^a   Kajikuri, Junko ^a   Watanabe, Yoshimasa ^a   Suzuki, Yoshikatsu ^a   Katsuya, Hirotada ^a   Itoh, Takeo ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Angiotensin II receptor; Endothelium; Intrapulmonary vein; Nitrate tolerance; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; APAMIN; CALCIUM CHANNEL BLOCKING AGENT; CHARYBDOTOXIN; DICLOFENAC; GLYCERYL TRINITRATE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL BLOCKING AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; SUPEROXIDE; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERANCE; ENDOTHELIUM; ENDOTHELIUM CELL; LUNG VASCULAR RESISTANCE; LUNG VEIN; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VEIN DILATATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSINS; ANIMALS; APAMIN; CALCIUM CHANNEL BLOCKERS; CHARYBDOTOXIN; DRUG INTERACTIONS; DRUG TOLERANCE; ENDOTHELIUM, VASCULAR; HYDRAZINES; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITROARGININE; NITROGLYCERIN; PULMONARY VEINS; RABBITS; RECEPTOR, ANGIOTENSIN, TYPE 1; SUPEROXIDES; TETRAZOLES; TIME FACTORS; VALINE; VASODILATION; VASODILATOR AGENTS;

EID: 19944378468     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706178     Document Type: Article

References (39)

1. ABRAMS, J. (1985). Hemodynamic effects of nitroglycerin and long-acting nitrates. Am. Heart J., 110, 216-224.
2. ABRAMS, J. (1996). Beneficial actions of nitrates in cardiovascular disease. Am. J. Cardiol., 77, 31C-37C.
3. ALLIOT, F., RUTIN, J., LEENEN, P.J. & PESSAC, B. (1999). Brain parenchyma vessels and the angiotensin system. Brain Res., 830, 101-112.
4. AUDl, S.H., DAWSON, C.A., RICKABY, D.A. & LINEMAN, J.H. (1991). Localization of the sites of pulmonary vasomotion by use of arterial and venous occlusion. J. Appl. Physiol., 70, 2126-2136.
5. BACK, M., WALCH, L., NOREL, X., GASCARD, J.P., MAZMANIAN, G. & BRINK, C. (2002). Modulation of vascular tone and reactivity by nitric oxide in porcine pulmonary arteries and veins. Acta. Physiol. Scand., 174, 9-15.
6. BARMAN, S.A. & TAYLOR, A.E. (1990). Effect of pulmonary venous pressure elevation on vascular resistance and compliance. Am. J. Physiol., 258, H1164-H1170.
7. BARNES, P.J. & LIU, S.F. (1995). Regulation of pulmonary vascular tone. Pharmacol. Rev., 47, 87-131.
8. BASSENGE, E. & STEWART, D.J. (1986). Effects of nitrates in various vascular sections and regions. Z. Kardiol., 75 (Suppl. 3), 1-7.
9. BERKENBOOM, G., FONTAINE, D., UNGER, P., BALDASSARRE, S., PREUMONT, N. & FONTAINE, J. (1999). Absence of nitrate tolerance after long-term treatment with ramipril: an endothelium-dependent mechanism. J. Cardiovasc. Pharmacol., 34, 547-553.
10. BUDHIRAJA, R., TUDER, R.M. & HASSOUN, P.M. (2004). Endothelial dysfunction in pulmonary hypertension. Circulation, 109, 159-165.
11. BURKHOFF, D. & TYBERG, J.V. (1993). Why does pulmonary venous pressure rise after onset of LV dysfunction: a theoretical analysis. Am. J. Physiol., 265, H1819-H1828.
12. CRISCIONE, L., DE GASPARD, M., BUHLMAYER, P., WHITEBREAD, S., RAMJOUE, H.P. & WOOD, J. (1993). Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype. Br. J. Pharmacol., 110, 761-771.
13. FELDMAN, R.L., PEPINE, C.J., CURRY JR, R.C. & CONTI, C.R. (1979). Coronary arterial responses to graded doses of nitroglycerin. Am. J. Cardiol., 43, 91-97.
14. GORI, T. & PARKER, J.D. (2002a). Nitrate tolerance: a unifying hypothesis. Circulation, 106, 2510-2513.
15. GORI, T. & PARKER, J.D. (2002b). The puzzle of nitrate tolerance: pieces smaller than we thought? Circulation, 106, 2404-2408.
16. +-channel inhibitors in rat isolated mesenteric arteries. Br. J. Pharmacol., 138, 1031-1035.
17. HUMBERT, M., MORRELL, N.W., ARCHER, S.L., STENMARK, K.R., MACLEAN, M.R., LANG, I.M., CHRISTMAN, B.W., WEIR, E.K., EICKELBERG, O., VOELKEL, N.F. & RABINOVITCH, M. (2004). Cellular and molecular pathobiology of pulmonary arterial hypertension. J. Am. Coll. Cardiol., 43, 13S-24S.
18. ITOH, T., KAJIKURI, J., TADA, T., SUZUKI, Y. & MABUCHI, Y. (2003). Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries. J. Physiol., 548, 893-906.
19. 2+ sensitivity of smooth muscle contraction without affecting myosin light chain phosphorylation. J. Biol. Chem., 270, 20400-20403.
20. KOHLER, K., WHEELER-SCHILLING, T., JURKLIES, B., GUENTHER, E. & ZRENNER, E. (1997). Angiotensin II in the rabbit retina. Vis. Neurosci., 14, 63-71.
21. KURZ, S., HINK, U., NICKENIG, G., BORTHAYRE, A.B., HARRISON, D.G. & MÜNZEL, T. (1999). Evidence for a causal role of the rennin-angiotensin system in nitrate tolerance. Circulation, 99, 3181-3187.
22. LAURSEN, J.B., MULSCH, A., BOESGAARD, S., MORDVINTCEV, P., TRAUTNER, S., GRUHN, N., NIELSEN-KUDSK, J.E., BUSSE, R. & ALDERSHVILE, J. (1996). In vivo nitrate tolerance is not associated with reduced bioconversion of nitroglycerin to nitric oxide. Circulation, 94, 2241-2247.
23. MIHM, M.J., COYLE, CM., JING, L. & BAUER, J.A. (1999). Vascular peroxynitrite formation during organic nitrate tolerance. J. Pharmacol. Exp. Ther., 291, 194-198.
24. MOLINA, C.R., ANDRESEN, J.W., RAPOPORT, R.M., WALDMAN, S. & MURAD, F. (1987). Effect of in vivo nitroglycerin therapy on endothelium-dependent and independent vascular relaxation and cyclic GMP accumulation in rat aorta. J. Cardiovasc. Pharmacol., 10, 371-378.
25. MOLLNAU, H., WENDT, M., SZOCS, K., LASSEGUE, B., SCHULZ, E., OELZE, M., LI, H., BODENSCHATZ, M., AUGUST, M., KLESCHYOV, A.L., TSILIMINGAS, N., WALTER, U., FORSTERMANN, U., MEINERTZ, T., GRIENDLING, K. & MÜNZEL, T. (2002). Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/ cGMP signaling. Circ. Res., 90, E58-E65.
26. MÜNZEL, T. & BASSENGE, E. (1996). Long-term angiotensin- converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo. Circulation, 93, 2052-2058.
27. MÜNZEL, T., HEITZER, T. & HARRISON, D.G. (1997). The physiology and pathophysiology of the nitric oxide/superoxide system. Herz, 22, 158-172.
28. MÜNZEL, T., LI, H., MOLLNAU, H., HINK, U., MATHEIS, E., HARTMANN, M., OELZE, M., SKATCHKOV, M., WARNHOLTZ, A., DUNCKER, L., MEINERTZ, T. & FORSTERMANN, U. (2000). Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability. Circ. Res., 86, E7-E12.
29. MÜNZEL, T., SAYEGH, H., FREEMAN, B.A., TARPEY, M.M. & HARRISON, D.G. (1995). Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J. Clin. Invest., 95, 187-194.
30. NAKANO, Y., KUSAMA, N., KAJIKURI, J., SUZUKI, Y., KANMURA, Y. & ITOH, T. (2004). Role of PKC in the attenuation of the cGMP-mediated relaxation of skinned resistance artery smooth muscle seen in glyceryl-trinitrate-tolerant rabbit. Br. J. Pharmacol., 141, 391-398.
31. NOREL, X., WALCH, L., GASCARD, J.P., DEMONTPREVILLE, V. & BRINK, C. (2004). Prostacyclin release and receptor activation: differential control of human pulmonary venous and arterial tone. Br. J. Pharmacol., 142, 788-796.
32. PARKER, J.D., FARRELL, B., FENTON, T., COHANIM, M. & PARKER, J.O. (1991). Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation, 84, 2336-2345.
33. PARKER, J.D. & PARKER, J.O. (1998). Nitrate therapy for stable angina pectoris. N. Engl. J. Med., 338, 520-531.
34. SHI, W., EIDELMAN, D.H. & MICHEL, R.P. (1997). Differential relaxant responses of pulmonary arteries and veins in lung explants of guinea pigs. J. Appl. Physiol., 83, 1476-1481.
35. SOFF, G.A., CORNWELL, T.L., CUNDIFF, D.L., GATELY, S. & LINCOLN, T.M. (1997). Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP. J. Clin. Invest., 100, 2580-2587.
36. STEWART, D.J., HOLTZ, J. & BASSENGE, E. (1987). Long-term nitroglycerin treatment: effect on direct and endothelium-mediated large coronary artery dilation in conscious dogs. Circulation, 75, 847-856.
37. TOWNSLEY, M.I., PITTS, V.H., ARDELL, J.L., ZHAO, Z. & JOHNSON JR, W.H. (1994). Altered pulmonary microvascular reactivity to norepinephrine in canine pacing-induced heart failure. Circ. Res., 75, 347-356.
38. YAMAKAWA, N., OHHASHI, M., WAGA, S. & ITOH, T. (1997). Role of endothelium in regulation of smooth muscle membrane potential and tone in the rabbit middle cerebral artery. Br. J. Pharmacol., 121, 1315-1322.
39. ZELIS, R. & MASON, D.T. (1975). Isosorbide dinitrate. Effect on the vasodilator response to nitroglycerin. JAMA, 234, 166-170.